Optimizing Outcomes Across the Pharma Value Chain Network featuring Axendia

The ability of bio-pharmaceutical manufacturers to deliver quality drug products during challenging market conditions is critical for ensuring sustainability over the long run. The COVID-19 pandemic underscored the need to transform the traditional bio-pharmaceutical supply chain to have greater agility and resiliency during market swings and periods of volatility.
 

Listen to this on-demand webinar as Pharmaceutical Outsourcing Editor-in-Chief Mike Auerbach has a lively discussion with industry experts Daniel Matlis, President and Founder, Axendia, and David Leitham, SVP and GM, Pharmaceutical Business Unit, AspenTech, as they address these hot-button topics:

  • What are the challenges that have limited the pharmaceutical industry from moving forward with digitalization?
  • What is digital maturity and why is it a requirement for pharmaceutical manufacturing?
  • Where should pharmaceutical companies begin their digitalization journey?

Learn more in this on-demand webinar.


Optimizing Outcomes Across the Pharma Value Chain Network featuring Axendia

Why we collect this data:

AspenTechは、当社の事業、可能な限り最善の製品やカスタマーサービスのご提供、そして全体的なユーザエクスペリエンスに関わるさまざまな理由でお客様の個人データを収集および処理する場合があります。当社はお客様の個人データを使用して適宜、アンケートや調査の管理、契約サービスの正確な提供、イベントへの登録、お客様の好みの理解、および不正または不正な活動の検出と防止を行う場合があります。個人データの収集と処理の詳細については、こちらからAspenTechのプライバシーおよびセキュリティポリシーを参照してください。

Optimizing Outcomes Across the Pharma Value Chain Network featuring Axendia

Hello . If this is not you

Thank you for viewing this on-demand webinar

If you weren't redirected, click here